BioSpace News Archive

Business

Amicus Therapeutics to Announce First Quarter 2024 Financial Results on May 9, 2024

Amicus Therapeutics announced that the Company will host a conference call and live audio webcast on Thursday, May 9, 2024, at 8:30 a.m. ET to discuss financial results for the first quarter ended March 31, 2024.

May 1, 2024
·
1 min read
Business

Pfizer Reports First-Quarter 2024 Results

Pfizer Inc. reported financial results for the first quarter of 2024 and raised its Adjusted diluted EPS guidance while maintaining all other components of its 2024 financial guidance.

May 1, 2024
·
37 min read
Genetown

Apellis Announces 11 Oral Presentations at the Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting

Apellis Pharmaceuticals, Inc. announced that 14 abstracts, 11 of which are oral presentations, will be presented at the Association for Research in Vision and Ophthalmology Annual Meeting to be held May 5 - 9 in Seattle.

May 1, 2024
·
8 min read
Business

PROCEPT BioRobotics Reports First Quarter 2024 Financial Results and Increases 2024 Revenue Guidance

PROCEPT BioRobotics® Corporation, a surgical robotics company focused on advancing patient care by developing transformative solutions in urology, reported unaudited financial results for the quarter ended March 31, 2024.

May 1, 2024
·
11 min read
Biotech Bay

Olema Oncology to Participate in Upcoming Investor Conferences in May 2024

Olema Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of targeted therapies for women’s cancers, announced that its management team will participate in the following upcoming investor conferences.

May 1, 2024
·
1 min read
Pharm Country

Johnson & Johnson Announces Plan by its Subsidiary, LLT Management LLC, to Resolve All Current and Future Ovarian Cancer Talc Claims Through a Consensual “Prepackaged” Reorganization

Johnson & Johnson announced a proposed Plan of Reorganization by its subsidiary, LLT Management LLC, for the comprehensive and final resolution of all current and future claims related to ovarian cancer arising from cosmetic talc litigation against it and its affiliates in the United States.

May 1, 2024
·
8 min read
Business

United Therapeutics Corporation Reports First Quarter 2024 Financial Results

United Therapeutics Corporation, a public benefit corporation, announced its financial results for the quarter ended March 31, 2024.

May 1, 2024
·
13 min read
Business

ADC Therapeutics to Host First Quarter 2024 Financial Results and Pipeline Update Conference Call on May 6, 2024

ADC Therapeutics SA announced that it will host a conference call and live webcast on Monday, May 6, 2024 at 8:30 a.m. EDT to report financial results for the first quarter 2024 and provide updates on recent progress against key catalysts from the pipeline.

May 1, 2024
·
4 min read
PolyPid to Participate in Citizens JMP Life Sciences Conference

PolyPid Ltd., a late-stage biopharma company aiming to improve surgical outcomes, announced that company management will present at the Citizens JMP Life Sciences Conference taking place in New York, NY, from May 13 – 14, 2024.

May 1, 2024
·
1 min read
Business

Kamada to Announce First Quarter 2024 Financial Results and Host Conference Call on May 8, 2024

Kamada Ltd. announced that it will release financial results for the first quarter ended March 31, 2024, prior to the open of the U.S. financial markets on Wednesday, May 8, 2024.

May 1, 2024
·
2 min read